Helena Engel

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

University of Freiburg(Current)

University Medical Center Freiburg

Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele

German Cancer Research Center

Max Planck Institute of Immunobiology and Epigenetics

Helena Engel is an author at University of Freiburg specializing in immunotherapy after transplantation, transplant immunology, and survival after allogeneic transplantation.

ORCID

Publications per year

2021–2024

Publications

Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation

Jenny N. H. G. Ho, Dominik Schmidt, Theresa Lowinus et al. · Blood · 2022 · 55 citations · Full text

Life Sciences, Immunology, Oncology +12

Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti–TIM-3 therapy in mice

Nana Talvard-Balland, Lukas M. Braun, Karen O. Dixon et al. · Journal of Clinical Investigation · 2024 · 18 citations · Full text

Life Sciences, Immunology, Oncology +17

finDr: A web server for in silico D-peptide ligand identification

Helena Engel, Felix Guischard, Fabian Krause et al. · Synthetic and Systems Biotechnology · 2021 · 11 citations · Full text

Pharmacy, Bioinformatics, Pharmacology +17

1–3 of 3